earticle

논문검색

Molecular Docking Studies of p21-Activated Kinase-1 (PAK1) Inhibitors

원문정보

초록

영어

The p21-activated kinase-1 (PAK1) has emerged as a potential target for anticancer therapy. It is overexpressed in ovarian, breast and bladder cancers. This suggests that PAK1 may contribute to tumorigenesis. 4-azaindole derivatives are reported as potent PAK1 inhibitors. The present work deals with the molecular docking studies of 4-azaindoles with PAK1. Probable binding mode of these inhibitors has been identified by molecular modeling. Docking results indicated that hydrogen bonding interactions with Glu345 and Leu347 are responsible for governing inhibitor potency of the compounds. Additionally, Val284, Val328, Met344 and Leu396 were found to be accountable for hydrophobic interactions inside the active site of PAK1

목차

Abstract
 1. Introduction
 2. Methodology
  2.1. Ligand Structure Preparation
  2.2. Protein Structure Preparation
  2.3. Molecular Docking
 3. Results and Discussion
 4. Conclusion
 References

저자정보

  • Anand Balupuri Department of Biomedical Sciences, College of Medicine, Chosun University, Gwangju 501-759, Korea
  • Pavithra K. Balasubramanian Department of Biomedical Science, Colleage of Medicine, Chosun University
  • Seung Joo Cho 조승주. Department of Biomedical Sciences, College of Medicine, Chosun University, Department of Cellular and Molecular Medicine, College of Medicine, Chosun University

참고문헌

자료제공 : 네이버학술정보

    함께 이용한 논문

      ※ 기관로그인 시 무료 이용이 가능합니다.
      ※ 학술발표대회집, 워크숍 자료집 중 4페이지 이내 논문은 '요약'만 제공되는 경우가 있으니, 구매 전에 간행물명, 페이지 수 확인 부탁 드립니다.

      • 4,000원

      0개의 논문이 장바구니에 담겼습니다.